Literature DB >> 9224224

Influence of age on symptoms at presentation in patients with community-acquired pneumonia.

J P Metlay1, R Schulz, Y H Li, D E Singer, T J Marrie, C M Coley, L J Hough, D S Obrosky, W N Kapoor, M J Fine.   

Abstract

BACKGROUND: Advanced age has become a well-recognized risk factor for death in patients with pneumonia. It may also be associated with reduced symptom reporting, raising the possibility that diagnosis and treatment may be delayed in older patients.
OBJECTIVE: To evaluate the association between age and the presenting symptoms in patients with community-acquired pneumonia.
METHODS: This study was conducted at inpatient and outpatient facilities at 3 university hospitals, 1 community hospital, and 1 staff-model health maintenance organization. Patients included adults (age > or = 18 years) with clinical and radiographic evidence of pneumonia, who were able to complete a baseline interview. The presence of 5 respiratory symptoms and 13 nonrespiratory symptoms were recorded during a baseline patient interview. A summary symptom score was computed as the total number of symptoms at presentation.
RESULTS: The 1812 eligible study patients were categorized into 4 age groups: 18 through 44 years (43%), 45 through 64 years (25%), 65 through 74 years (17%), and 75 years or older (15%). For 17 of the 18 symptoms, there were significant decreases in reported prevalence with increasing age (P < .01). In a linear regression analysis, controlling for patient demographics, comorbidity, and severity of illness at presentation, older age remained associated with lower symptom scores (P < .001).
CONCLUSIONS: Respiratory and nonrespiratory symptoms are less commonly reported by older patients with pneumonia, even after controlling for the increased comorbidity and illness severity in these older patients. Recognition of this phenomenon by clinicians and patients is essential given the increased mortality in elderly patients with pneumonia.

Entities:  

Mesh:

Year:  1997        PMID: 9224224

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  72 in total

Review 1.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Evaluation of a computerized diagnostic decision support system for patients with pneumonia: study design considerations.

Authors:  D Aronsky; K J Chan; P J Haug
Journal:  J Am Med Inform Assoc       Date:  2001 Sep-Oct       Impact factor: 4.497

4.  Community-Acquired Pneumonia: An Overview.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

5.  Development and validation of a short questionnaire in community acquired pneumonia.

Authors:  R El Moussaoui; B C Opmeer; P M M Bossuyt; P Speelman; C A J M de Borgie; J M Prins
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

6.  [Competence network "community acquired pneumonia" (CAPNETZ). A first interim report].

Authors:  T Welte; R Marre; N Suttorp
Journal:  Internist (Berl)       Date:  2004-04       Impact factor: 0.743

Review 7.  Pneumonia: update on diagnosis and management.

Authors:  Zara Hoare; Wei Shen Lim
Journal:  BMJ       Date:  2006-05-06

8.  ICD-10 codes are a valid tool for identification of pneumonia in hospitalized patients aged > or = 65 years.

Authors:  S A Skull; R M Andrews; G B Byrnes; D A Campbell; T M Nolan; G V Brown; H A Kelly
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

9.  [Community-acquired pneumonia: a disease of the elderly].

Authors:  T Welte
Journal:  Z Gerontol Geriatr       Date:  2011-08       Impact factor: 1.281

Review 10.  Pneumonia and empyema: causal, casual or unknown.

Authors:  Lindsay McCauley; Nathan Dean
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.